Canoo Inc. Announces Third Quarter 2024 Results
Quarterly revenue of $0.9 million, and year-to-date revenue of $1.50 millionQuarterly Adjusted…
INmune Bio Inc. Announces Final Enrollment of 208 Patients in Phase 2 Trial in Early Alzheimer’s Disease
Boca Raton, Florida, Nov. 13, 2024 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ:…
Corvus Pharmaceuticals Announces New Data Highlighting Potential of Ciforadenant to Overcome Immunotherapy Resistance in Metastatic Castration Resistant Prostate Cancer
Data presented in an oral session at the Society for Immunotherapy of…
Precipio Announces Q3-2024 Shareholder Update Call
Conference Call to be held on November 18, 2024, at 5:00 PM…
Belite Bio Announces Exercise of Warrants for US$28.75 Million Gross Proceeds
November 03, 2024 16:00 ET | Source: Belite Bio, Inc SAN DIEGO,…
LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
November 01, 2024 18:32 ET | Source: LENSAR, Inc. ORLANDO, Fla., Nov.…